Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer

BACKGROUND AND PURPOSE: Treatment of intermediate and high-risk prostate cancer with a high BED has been shown to increase recurrence free survival (RFS). While high dose rate (HDR) brachytherapy, given as a boost is effective in delivering a high BED, many patients are not candidates for the proced...

Descripción completa

Detalles Bibliográficos
Autores principales: Anwar, Mekhail, Weinberg, Vivian, Seymour, Zachary, Hsu, I. Joe, Roach, Mack, Gottschalk, Alex R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4721063/
https://www.ncbi.nlm.nih.gov/pubmed/26792201
http://dx.doi.org/10.1186/s13014-016-0585-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4721063/
https://www.ncbi.nlm.nih.gov/pubmed/26792201
http://dx.doi.org/10.1186/s13014-016-0585-y

Ejemplares similares